Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. In more than 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of mRNA, to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across seven modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed.